The pleiotropic of GLP-1/GLP-1R axis in central nervous system diseases

被引:24
|
作者
Zhang, LongQing [1 ]
Zhang, Wen [1 ]
Tian, XueBi [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Anesthesiol, Wuhan, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
GLP-1; GLP-1R; CNS diseases; neuroprotection; GLUCAGON-LIKE PEPTIDE-1; BLOOD-BRAIN-BARRIER; GLP-1 RECEPTOR AGONIST; SPINAL-CORD-INJURY; MPTP MOUSE MODEL; CLOZAPINE-ASSOCIATED OBESITY; ALCOHOL-MEDIATED BEHAVIORS; PARKINSONS-DISEASE; HEMORRHAGIC TRANSFORMATION; SYNAPTIC PLASTICITY;
D O I
10.1080/00207454.2021.1924707
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Glucagon-like peptide-1(GLP-1) is a multifunctional polypeptide throughout the lifespan via activating Glucagon-like peptide-1 receptor (GLP-1R).GLP-1 can affect food ingestion, enhance the secretion of insulin from pancreatic islets induced by glucose and be utilized to treat type 2 diabetes mellitus(T2DM).But, accumulating evidences from the decades suggest that activation GLP-1R can not only regulate the blood glucose, but also sustain the homeostasis of intracellular environment and protect neuron from various damaged responses such as oxidative stress, inflammation, excitotoxicity, ischemia and so on. And more and more pre-clinical and clinical studies identified that GLP-1 and its analogues may play a significant role in improving multiple central nervous system (CNS) diseases including neurodegenerative diseases, epilepsy, mental disorders, ischemic stroke, hemorrhagic stroke, traumatic brain injury, spinal cord injury, chronic pain, addictive disorders, other diseases neurological complications and so on. In order to better reveal the relationship between GLP-1/GLP-1R axis and the growth, development and survival of neurons, herein, this review is aimed to summarize the multi-function of GLP-1/GLP-1R axis in CNS diseases.
引用
收藏
页码:473 / 491
页数:19
相关论文
共 50 条
  • [41] Pharmacology characterisation of a novel GLP-1R agonist GSBR-2657 in a new humanised GLP-1R mouse model
    Mao, T.
    Zhang, H.
    Fang, X.
    Zhan, S.
    Wang, T.
    Guan, Z.
    Zhang, J.
    Lin, X.
    Lei, H.
    Zhang, F.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S321 - S321
  • [42] Computational insight into conformational states of glucagon-like peptide-1 receptor (GLP-1R) and its binding mode with GLP-1
    Zhang, Juan
    Gu, Shikai
    Sun, Xianqiang
    Li, Weihua
    Tang, Yun
    Liu, Guixia
    RSC ADVANCES, 2016, 6 (16): : 13490 - 13497
  • [43] Effects of metformin on the expression of GLP-1R in the enteric nervous system of type 2 diabetic rats
    Qu, Jun-sheng
    Hou, Ning-ning
    Pan, Rui-yan
    Han, Hai-lin
    Yan, Qing-tao
    Zhang, Yi-jun
    Qu, Mei-hua
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 89 - 89
  • [44] DJB SURGERY ENHANCES INTESTINAL AEROBIC OXIDATION IN T2DM RATS BY ACTIVATING GLP-1/GLP-1R SIGNAL
    Huaijie, W.
    Lulu, X.
    Qingtao, Y.
    Lei, C.
    Yuanyuan, T.
    Meihua, Q.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A203 - A204
  • [45] Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases
    Hoelscher, Christian
    JOURNAL OF ENDOCRINOLOGY, 2014, 221 (01) : T31 - T41
  • [46] GLP-1 Val8: A Biased GLP-1R Agonist with Altered Binding Kinetics and Impaired Release of Pancreatic Hormones in Rats
    van der Velden, Wijnand J. C.
    Smit, Florent X.
    Christiansen, Charlotte B.
    Moller, Thor C.
    Hjorto, Gertrud M.
    Larsen, Olav
    Schiellerup, Sine P.
    Brauner-Osborne, Hans
    Holst, Jens J.
    Hartmann, Bolette
    Frimurer, Thomas M.
    Rosenkilde, Mette M.
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2021, 4 (01) : 296 - 313
  • [47] Discovery of Novel GLP-1R Interacting Proteins
    Dai, Feihan
    Bhattacharjee, Alpana
    Wheeler, Michael
    DIABETES, 2014, 63 : A449 - A449
  • [48] Structure-activity studies of the interaction of GLP-1 with GLP-1R.
    Moy, KA
    Haines, DR
    Weight, A
    Worrall, CI
    Beinborn, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U121 - U121
  • [49] GLP-1R agonist medications for addiction treatment
    Volkow, Nora D.
    Xu, Rong
    ADDICTION, 2025, 120 (02) : 198 - 200
  • [50] Pitfalls in the Detection of Insulinomas with GLP-1R Imaging
    Antwi, Kwadwo
    Hepprich, Matthias
    Reubi, Jean Claude
    Fani, Melpomeni
    Fani, Melpomeni
    Rottenburger, Christof
    Nicolas, Guillaume
    Kaul, Felix
    Christ, Emanuel
    Wild, Damian
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61